Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 23;9(5):165.
doi: 10.3390/jcdd9050165.

A Systematic Review of Adherence to Immunosuppression among Pediatric Heart Transplant Patients

Affiliations
Review

A Systematic Review of Adherence to Immunosuppression among Pediatric Heart Transplant Patients

Keira Nassetta et al. J Cardiovasc Dev Dis. .

Abstract

After pediatric heart transplant, commitment to lifelong immunosuppression is crucial to maintaining graft health. However, a review of the current literature surrounding adherence to immunosuppression in pediatric heart transplant patients is lacking. This systematic review aims to summarize the current landscape of adherence to immunosuppression in pediatric heart transplant patients. We conducted searches in PubMed MEDLINE, Embase, CENTRAL register of Controlled Trials (Wiley), and Scopus, from inception to March 2020. Studies were eligible if they outlined an aspect of adherence to immunosuppression and the measurement of adherence was performed with an objective or otherwise validated measure of adherence (e.g., drug levels, adherence questionnaires). The titles/abstracts of 880 articles were reviewed. After initial screening, 106 articles underwent full text review. As such, 14 articles were included in the final review. Baseline adherence estimates varied greatly, with most values between 40% and 70%. Nonadherence to immunosuppression is associated with worse outcomes (rejection, hospitalization, mortality), impaired quality of life, and mental health concerns in pediatric heart transplant patients. As nonadherence to immunosuppression is common and associated with worse outcomes, there is a need for further development and evaluation of interventions in this space.

Keywords: adherence; compliance; heart transplant; immunosuppression; pediatric; rejection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA Flow Diagram for the included studies.
Figure 2
Figure 2
Reported non-adherence rates.

References

    1. Thrush P.T., Hoffman T.M. Pediatric heart transplantation-indications and outcomes in the current era. J. Thorac. Dis. 2014;6:1080–1096. doi: 10.3978/j.issn.2072-1439.2014.06.16. - DOI - PMC - PubMed
    1. D’Addese L., Joong A., Burch M., Pahl E. Pediatric heart transplantation in the current era. Curr. Opin. Pediatr. 2019;31:583–591. doi: 10.1097/MOP.0000000000000805. - DOI - PubMed
    1. Rossano J.W., Singh T.P., Cherikh W.S., Chambers D.C., Harhay M.O., Hayes D., Jr., Hsich E., Khush K.K., Meiser B., Potena L., et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report-2019; Focus theme: Donor and recipient size match. J. Heart Lung Transplant. 2019;38:1028–1041. doi: 10.1016/j.healun.2019.08.002. - DOI - PMC - PubMed
    1. Azzi J.R., Sayegh M.H., Mallat S.G. Calcineurin Inhibitors: 40 Years Later, Can’t Live without …. J. Immunol. 2013;191:5785–5791. doi: 10.4049/jimmunol.1390055. - DOI - PubMed
    1. Oliva M., Singh T.P., Gauvreau K., Vanderpluym C.J., Bastardi H.J., Almond C.S. Impact of medication non-adherence on survival after pediatric heart transplantation in the U.S.A. J. Heart Lung Transplant. 2013;32:881–888. doi: 10.1016/j.healun.2013.03.008. - DOI - PubMed